Nicola M. Tomas (@nicolamtomas) 's Twitter Profile
Nicola M. Tomas

@nicolamtomas

ID: 1479579327960432643

calendar_today07-01-2022 22:24:42

228 Tweet

272 Followers

225 Following

Science Immunology (@sciimmunology) 's Twitter Profile Photo

Scientists have developed a potential therapeutic approach for patients with #immunodeficiency due to neutralizing anti-interferon-γ #autoantibodies. Chang Gung University Université de Lausanne Learn more in Science #Immunology: scim.ag/44tK6Wx

Scientists have developed a potential therapeutic approach for patients with #immunodeficiency due to neutralizing anti-interferon-γ #autoantibodies. <a href="/ChangGungUniv/">Chang Gung University</a> <a href="/unil/">Université de Lausanne</a> 

Learn more in Science #Immunology: scim.ag/44tK6Wx
Nicola M. Tomas (@nicolamtomas) 's Twitter Profile Photo

IgA nephropathy is one of the most evolving fields in nephrology - our view on the recent advances in understanding its pathogenesis out CKJ. HCKH_Hamburg academic.oup.com/ckj/advance-ar…

Tobias B. Huber (@tobias_b_huber) 's Twitter Profile Photo

Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases academic.oup.com/ckj/article/18…

Prof Dr. rer. nat. Nicole Endlich (@endlichnicole) 's Twitter Profile Photo

PodoSciStream: Fantastic talk of Complement and B cell targeting given by Dr. Nicola M. Tomas (University Medical Center Hamburg-Eppendorf) at the IPC in Hamburg. Congratulation for such amazing studies! 👏 🐙

PodoSciStream: Fantastic talk of Complement and B cell targeting given by Dr. <a href="/NicolaMTomas/">Nicola M. Tomas</a> (University Medical Center Hamburg-Eppendorf) at the IPC in Hamburg. Congratulation for such amazing studies! 👏 🐙
Gunnar Henrik Heine (@gunnar_heine) 's Twitter Profile Photo

The Future of TTP treatment might become PE-free: MAYARI (single arm, prospective trial) presented as late-breaker ISTH 2025 by Paul Coppo, Paul Brinkkötter et al. 🙏

The Future of TTP treatment might become PE-free:

MAYARI (single arm, prospective trial) presented as late-breaker <a href="/isth/">ISTH</a> 2025 by Paul Coppo, Paul Brinkkötter et al.
🙏
Nicola M. Tomas (@nicolamtomas) 's Twitter Profile Photo

What a sparkling meeting on B cell targeting for immune-mediated kidney diseases in Panama! And good to see so many friends and collaborators. Thank you KDIGO Brad H Rovin !

What a sparkling meeting on B cell targeting for immune-mediated kidney diseases in Panama! And good to see so many friends and collaborators. Thank you <a href="/goKDIGO/">KDIGO</a> <a href="/BradRovin/">Brad H Rovin</a> !
Daniel Díaz - García (@danieldiaznf) 's Twitter Profile Photo

Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy ▫️3 cases ▫️Detected by immunoprecipitation/ELISA ▫️Their high specificity for podocytopathies in combination with a strong correlation with disease activity hold the potential for a non-invasive diagnosis

Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy

▫️3 cases

▫️Detected by immunoprecipitation/ELISA

▫️Their high specificity for podocytopathies in combination with a strong correlation with disease activity hold the potential for a non-invasive diagnosis